GCP
ZOM

GSA Capital Partners’s Zomedica Corp. ZOM Stock Holding History

GSA Capital Partners’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,995,874
Closed -$438K – 2115
2024
Q2 		$438K Buy
2,995,874
+2,750,887
+1,123% +$412K 0.03% 1047
2024
Q1 		$36K Buy
+244,987
New +$34.3K ﹤0.01% 1542
2022
Q3 		– Sell
-1,272,480
Closed -$280K – 2024
2022
Q2 		$280K Buy
1,272,480
+44,421
+4% +$11.3K 0.04% 870
2022
Q1 		$414K Buy
1,228,059
+31,377
+3% +$10.3K 0.06% 670
2021
Q4 		$367K Buy
+1,196,682
New +$539K 0.05% 804
2021
Q3 		– Sell
-103,232
Closed -$86K – 1928
2021
Q2 		$86K Buy
+103,232
New +$96.2K 0.01% 1255

Other funds holding ZOM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $376B AUM 19.32% 1-Year Est. Return